Nerve growth factor and neuropeptides circulating levels in systemic sclerosis (scleroderma)

M. Matucci-Cerinic; R. Giacomelli; A. Pignone; M. Cagnoni; S. Generini; R. Casale; P. Cipriani; A. Del Rosso; P. Tirassa; Y. T. Konttinen; B. M. Kahaleh; P. S. Fan; M. Paoletti; C. Marchesi; L. Aloe; M. L. Cagnoni

doi:10.1136/ard.60.5.487

Nerve growth factor and neuropeptides circulating levels in systemic sclerosis (scleroderma)

M. Matucci-Cerinic, R. Giacomelli, A. Pignone, M. Cagnoni, S. Generini, R. Casale, P. Cipriani, A. Del Rosso, P. Tirassa, Y. T. Konttinen, B. M. Kahaleh, P. S. Fan, M. Paoletti, C. Marchesi, L. Aloe, M. L. Cagnoni

Istituti Clinici Scientifici Maugeri Spa – Società Benefit

Research output: Contribution to journal › Article

Abstract

Objective - To determine the circulating levels of nerve growth factor (NGF), neuropeptide Y (NPY), and vasoactive intestinal peptide (VIP) in systemic sclerosis (SSc), and to correlate these levels with clinical and laboratory features. Methods - Forty four patients with SSc were evaluated for circulating NGF (immunoenzymatic assay), NPY and VIP (radioimmunoassay), anticentromere and antitopoisomerase I autoantibodies, lung disease (pulmonary function tests with carbon monoxide transfer factor (TLCO), ventilation scintiscan with ^99mTc DTPA radioaerosol, high resolution computed tomography (HRCT), pulmonary pressure (echo colour Doppler)), heart disease (standard and 24 ECG, echocardiography), cutaneous involvement (skin score), joint involvement (evidence of tender or swollen joints, or both), peripheral nervous system (PNS) involvement (electromyography), rheumatoid factor, angiotensin converting enzyme (fluorimetric method), von Willebrand factor (ELISA), and erythrocyte sedimentation rate (ESR) (Westergren). Results - Circulating NGF levels in SSc were significantly increased compared with controls (p

Original language	English
Pages (from-to)	487-494
Number of pages	8
Journal	Annals of the Rheumatic Diseases
Volume	60
Issue number	5
DOIs	https://doi.org/10.1136/ard.60.5.487
Publication status	Published - 2001

Fingerprint

ASJC Scopus subject areas

Rheumatology
Immunology

Cite this

Matucci-Cerinic, M., Giacomelli, R., Pignone, A., Cagnoni, M., Generini, S., Casale, R., Cipriani, P., Del Rosso, A., Tirassa, P., Konttinen, Y. T., Kahaleh, B. M., Fan, P. S., Paoletti, M., Marchesi, C., Aloe, L., & Cagnoni, M. L. (2001). Nerve growth factor and neuropeptides circulating levels in systemic sclerosis (scleroderma). Annals of the Rheumatic Diseases, 60(5), 487-494. https://doi.org/10.1136/ard.60.5.487

Nerve growth factor and neuropeptides circulating levels in systemic sclerosis (scleroderma). / Matucci-Cerinic, M.; Giacomelli, R.; Pignone, A.; Cagnoni, M.; Generini, S.; Casale, R.; Cipriani, P.; Del Rosso, A.; Tirassa, P.; Konttinen, Y. T.; Kahaleh, B. M.; Fan, P. S.; Paoletti, M.; Marchesi, C.; Aloe, L.; Cagnoni, M. L.

In: Annals of the Rheumatic Diseases, Vol. 60, No. 5, 2001, p. 487-494.

Research output: Contribution to journal › Article

Matucci-Cerinic, M, Giacomelli, R, Pignone, A, Cagnoni, M, Generini, S, Casale, R, Cipriani, P, Del Rosso, A, Tirassa, P, Konttinen, YT, Kahaleh, BM, Fan, PS, Paoletti, M, Marchesi, C, Aloe, L & Cagnoni, ML 2001, 'Nerve growth factor and neuropeptides circulating levels in systemic sclerosis (scleroderma)', Annals of the Rheumatic Diseases, vol. 60, no. 5, pp. 487-494. https://doi.org/10.1136/ard.60.5.487

Matucci-Cerinic, M. ; Giacomelli, R. ; Pignone, A. ; Cagnoni, M. ; Generini, S. ; Casale, R. ; Cipriani, P. ; Del Rosso, A. ; Tirassa, P. ; Konttinen, Y. T. ; Kahaleh, B. M. ; Fan, P. S. ; Paoletti, M. ; Marchesi, C. ; Aloe, L. ; Cagnoni, M. L. / Nerve growth factor and neuropeptides circulating levels in systemic sclerosis (scleroderma). In: Annals of the Rheumatic Diseases. 2001 ; Vol. 60, No. 5. pp. 487-494.

@article{0deee09be33e4dfeb8b2f6463e0545d2,

title = "Nerve growth factor and neuropeptides circulating levels in systemic sclerosis (scleroderma)",

abstract = "Objective - To determine the circulating levels of nerve growth factor (NGF), neuropeptide Y (NPY), and vasoactive intestinal peptide (VIP) in systemic sclerosis (SSc), and to correlate these levels with clinical and laboratory features. Methods - Forty four patients with SSc were evaluated for circulating NGF (immunoenzymatic assay), NPY and VIP (radioimmunoassay), anticentromere and antitopoisomerase I autoantibodies, lung disease (pulmonary function tests with carbon monoxide transfer factor (TLCO), ventilation scintiscan with 99mTc DTPA radioaerosol, high resolution computed tomography (HRCT), pulmonary pressure (echo colour Doppler)), heart disease (standard and 24 ECG, echocardiography), cutaneous involvement (skin score), joint involvement (evidence of tender or swollen joints, or both), peripheral nervous system (PNS) involvement (electromyography), rheumatoid factor, angiotensin converting enzyme (fluorimetric method), von Willebrand factor (ELISA), and erythrocyte sedimentation rate (ESR) (Westergren). Results - Circulating NGF levels in SSc were significantly increased compared with controls (p",

author = "M. Matucci-Cerinic and R. Giacomelli and A. Pignone and M. Cagnoni and S. Generini and R. Casale and P. Cipriani and {Del Rosso}, A. and P. Tirassa and Konttinen, {Y. T.} and Kahaleh, {B. M.} and Fan, {P. S.} and M. Paoletti and C. Marchesi and L. Aloe and Cagnoni, {M. L.}",

year = "2001",

doi = "10.1136/ard.60.5.487",

language = "English",

volume = "60",

pages = "487--494",

journal = "Annals of the Rheumatic Diseases",

issn = "0003-4967",

publisher = "BMJ Publishing Group",

number = "5",

}

TY - JOUR

T1 - Nerve growth factor and neuropeptides circulating levels in systemic sclerosis (scleroderma)

AU - Matucci-Cerinic, M.

AU - Giacomelli, R.

AU - Pignone, A.

AU - Cagnoni, M.

AU - Generini, S.

AU - Casale, R.

AU - Cipriani, P.

AU - Del Rosso, A.

AU - Tirassa, P.

AU - Konttinen, Y. T.

AU - Kahaleh, B. M.

AU - Fan, P. S.

AU - Paoletti, M.

AU - Marchesi, C.

AU - Aloe, L.

AU - Cagnoni, M. L.

PY - 2001

Y1 - 2001

N2 - Objective - To determine the circulating levels of nerve growth factor (NGF), neuropeptide Y (NPY), and vasoactive intestinal peptide (VIP) in systemic sclerosis (SSc), and to correlate these levels with clinical and laboratory features. Methods - Forty four patients with SSc were evaluated for circulating NGF (immunoenzymatic assay), NPY and VIP (radioimmunoassay), anticentromere and antitopoisomerase I autoantibodies, lung disease (pulmonary function tests with carbon monoxide transfer factor (TLCO), ventilation scintiscan with 99mTc DTPA radioaerosol, high resolution computed tomography (HRCT), pulmonary pressure (echo colour Doppler)), heart disease (standard and 24 ECG, echocardiography), cutaneous involvement (skin score), joint involvement (evidence of tender or swollen joints, or both), peripheral nervous system (PNS) involvement (electromyography), rheumatoid factor, angiotensin converting enzyme (fluorimetric method), von Willebrand factor (ELISA), and erythrocyte sedimentation rate (ESR) (Westergren). Results - Circulating NGF levels in SSc were significantly increased compared with controls (p

AB - Objective - To determine the circulating levels of nerve growth factor (NGF), neuropeptide Y (NPY), and vasoactive intestinal peptide (VIP) in systemic sclerosis (SSc), and to correlate these levels with clinical and laboratory features. Methods - Forty four patients with SSc were evaluated for circulating NGF (immunoenzymatic assay), NPY and VIP (radioimmunoassay), anticentromere and antitopoisomerase I autoantibodies, lung disease (pulmonary function tests with carbon monoxide transfer factor (TLCO), ventilation scintiscan with 99mTc DTPA radioaerosol, high resolution computed tomography (HRCT), pulmonary pressure (echo colour Doppler)), heart disease (standard and 24 ECG, echocardiography), cutaneous involvement (skin score), joint involvement (evidence of tender or swollen joints, or both), peripheral nervous system (PNS) involvement (electromyography), rheumatoid factor, angiotensin converting enzyme (fluorimetric method), von Willebrand factor (ELISA), and erythrocyte sedimentation rate (ESR) (Westergren). Results - Circulating NGF levels in SSc were significantly increased compared with controls (p

UR - http://www.scopus.com/inward/record.url?scp=0035022631&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035022631&partnerID=8YFLogxK

U2 - 10.1136/ard.60.5.487

DO - 10.1136/ard.60.5.487

M3 - Article

C2 - 11302871

AN - SCOPUS:0035022631

VL - 60

SP - 487

EP - 494

JO - Annals of the Rheumatic Diseases

JF - Annals of the Rheumatic Diseases

SN - 0003-4967

IS - 5

ER -

Access to Document

10.1136/ard.60.5.487